Search alternatives:
patient decrease » point decrease (Expand Search), transient decrease (Expand Search), largest decrease (Expand Search)
values decrease » values increased (Expand Search), largest decrease (Expand Search)
e decrease » we decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
_ patient » _ patients (Expand Search)
Showing 1 - 20 results of 17,759 for search '(((( a ((e decrease) OR (mean decrease)) ) OR ( _ patient decrease ))) OR ( _ values decrease ))', query time: 0.67s Refine Results
  1. 1
    Maximum IFN concentrations are decreased in severe patients.

    Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Naringenin decreases mitochondrial function.

    Naringenin decreases mitochondrial function. by Lauren A. Eanes (20995499)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Naringenin decreases total cell viability.

    Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

    Published 2025
    Save to List
    Saved in:
  4. 4
    <i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages.

    <i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

    Published 2024
    Save to List
    Saved in:
  5. 5
    MAP3K1, MAPK11, and PPP2R1A knockdown decreased ECM internalisation.

    MAP3K1, MAPK11, and PPP2R1A knockdown decreased ECM internalisation. by Montserrat Llanses Martinez (17797522)

    Published 2024
    Save to List
    Saved in:
  6. 6
    Loss of Vps34 is associated with decreased eTreg survival but intact activation.

    Loss of Vps34 is associated with decreased eTreg survival but intact activation. by Erienne G. Norton (9612079)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC.

    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC. by Hongliang Chen (538815)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Tetrandrine decreases Mtb antigen presentation.

    Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Lymphocytes decreased in mouse pneumonia model.

    Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Cancer virtual patients with decreased initial neutrophil concentrations have higher viral load peaks.

    Cancer virtual patients with decreased initial neutrophil concentrations have higher viral load peaks. by Sonia T. Gazeau (21512764)

    Published 2025
    “…<p><b>A)</b> Viral loads in mild <b>a</b><b>-c)</b> and severe virtual patients <b>d</b><b>-f)</b>. <b>B)</b> Sensitivity analysis determined that decreasing <i>N</i>0 (the initial concentration of neutrophils) causes higher peak viral load and peak IL-6 and IFN concentrations.…”
    Save to List
    Saved in:
  12. 12
    Madrasin decreases transcription of protein-coding genes.

    Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

    Published 2024
    Save to List
    Saved in:
  13. 13
    PDRN decreases the expression of cellular aging markers.

    PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

    Published 2025
    Save to List
    Saved in:
  14. 14
    K1 expression decreases in HA15 treated cells.

    K1 expression decreases in HA15 treated cells. by Guillermo Najarro (19964572)

    Published 2024
    Save to List
    Saved in:
  15. 15
    Figure 7 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin

    Figure 7 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

    Published 2025
    “…<b>K,</b> Created with BioRender.com. Winiarska, M. (2025) <a href="https://BioRender.com/t34e524" target="_blank">https://BioRender.com/t34e524</a>.…”
    Save to List
    Saved in:
  16. 16
    Wnt signaling decreases the recruitment of RAB8a to basal bodies.

    Wnt signaling decreases the recruitment of RAB8a to basal bodies. by Cheng Yuan (160315)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Decreased spindle microtubules in CAMSAP2 KO cells.

    Decreased spindle microtubules in CAMSAP2 KO cells. by Naoko Nishizawa (20536299)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: